Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Sleep Apnea Syndrome
NCT00816829Phase 2Terminated
- Sponsor
- Solvay
- Start
- Sep 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate in sleep apnea syndrome (SAS), sponsored by Solvay. Started Sep 2005; status: terminated.
02
Drugs
fenofibrate
03
Conditions
sleep apnea syndrome (SAS)
Beyond the preview
Go deeper on NCT00816829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816829.